External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home EHA 2023
Roche and Genentech at

EHA 2023

June 08 - June 11
Frankfurt, Germany / Virtual (Hybrid)
ehaweb.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:45 PM
Duration 5mins Frankfurt, Germany / Virtual (Hybrid)
Diffuse large B-cell lymphoma treatment in the modern era: decision-making and practical management
Reinhardt C, Osborne W, Hutchings M, Jäger U
Haematology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:45 PM
Duration 15mins Panorama 1
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomised CLL14 study
Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, Chang YM, Fink A, Tausch E, Schneider C, Ritgen M, Kreuzer K, Sivcheva L, Niemann C, Schwarer A, Pueyo JL, Weinkove R, Strumberg D, Kilfoyle A, Runkel E, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek M, Fischer K
Haematology | Chronic Lymphoblastic Leukaemia

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:00 PM
Duration 15mins Illusion
THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS
Röth A, He G, Brodsky A, Chai-Adisaksopha C, Dumagay T, Demichelis Gómez MR, Höglund M, Kelly R, Lee J-H, Nishimura J-I, Obara N, Risitano A, Gaya Valls A, Appius A, Gentile B, Negricea R, Zhang Z, Buatois S, Han B.
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 15mins Illusion
PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
Scheinberg, P, Villa Cle D, Edwards J, Giai V, Hus M, Kim JS, Barrebetxea Lekue C, Nagy Z, Nur E, Pans JP, Ueda Y, Yenerel MN, Appius A, Balachandran N, Chebon S, Gentile B, Buatois S, Kulasekararaj A
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:00 PM
Duration 5mins Frankfurt, Germany / Virtual (Hybrid)
Paroxysmal nocturnal hemoglobinuria (PNH) outcomes and recent therapeutic developments in complement inhibition
Roth A, Munir T, Wagner O, Panse J
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:45 AM
Duration 15mins FestHalle
Final 7-year follow up and retreatment substudy analysis of MURANO: venetoclax-rituximab (VenR)-treated patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL)
Kater AP, Harrup R, Kipps TJ, Eichhorst B, Owen CJ, Assouline, S, Lamanna N, Robak T, De la Serna, J, Jaeger U, Cartron G, Montillo M, Mellink C, Chyla B, Thadani-Mulero M, Lefebure M, Jiang Y, Millen R, Boyer M, Seymour JF
Haematology | Chronic Lymphoblastic Leukaemia

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.